Fort Washington Investment Advisors Inc. OH Sells 8,220 Shares of Encompass Health Corporation $EHC

Fort Washington Investment Advisors Inc. OH lessened its holdings in Encompass Health Corporation (NYSE:EHC) by 3.8% during the third quarter, HoldingsChannel.com reports. The firm owned 208,456 shares of the company’s stock after selling 8,220 shares during the period. Fort Washington Investment Advisors Inc. OH’s holdings in Encompass Health were worth $26,478,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Newbridge Financial Services Group Inc. increased its stake in Encompass Health by 112.5% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 425 shares of the company’s stock valued at $52,000 after buying an additional 225 shares during the last quarter. Employees Retirement System of Texas acquired a new stake in shares of Encompass Health in the second quarter valued at about $57,000. Parkside Financial Bank & Trust raised its holdings in Encompass Health by 179.5% during the second quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock worth $59,000 after acquiring an additional 307 shares in the last quarter. Park Place Capital Corp acquired a new position in Encompass Health during the second quarter valued at approximately $72,000. Finally, TD Waterhouse Canada Inc. grew its stake in Encompass Health by 68,000.0% in the second quarter. TD Waterhouse Canada Inc. now owns 681 shares of the company’s stock valued at $82,000 after purchasing an additional 680 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Barclays increased their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, November 23rd. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Finally, Bank of America lifted their price target on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Two research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $142.86.

Encompass Health Stock Performance

NYSE EHC opened at $107.67 on Wednesday. The stock has a market cap of $10.83 billion, a PE ratio of 20.35, a P/E/G ratio of 1.90 and a beta of 0.73. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14. The firm has a 50-day moving average of $113.63 and a 200-day moving average of $117.75. Encompass Health Corporation has a 52-week low of $87.85 and a 52-week high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The firm had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, sell-side analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s payout ratio is 14.37%.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.